PDB Short entry for 1KLM HEADER NUCLEOTIDYLTRANSFERASE 17-MAR-97 1KLM TITLE HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.7.49; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; COMPND 8 CHAIN: B; COMPND 9 EC: 2.7.7.49; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: HXB2 ISOLATE; SOURCE 5 CELL_LINE: 293; SOURCE 6 GENE: POL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: 293; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 12 ORGANISM_TAXID: 11676; SOURCE 13 STRAIN: HXB2 ISOLATE; SOURCE 14 CELL_LINE: 293; SOURCE 15 GENE: POL; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: 293 KEYWDS AIDS, HIV-1, ENDONUCLEASE, RNA-DIRECTED DNA POLYMERASE, HIV-1 REVERSE KEYWDS 2 TRANSCRIPTASE, BHAP U-90152, DRUG, NUCLEOTIDYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.REN,R.M.ESNOUF,D.K.STAMMERS,D.I.STUART REVDAT 4 03-APR-24 1KLM 1 REMARK SEQADV LINK REVDAT 3 18-JUL-12 1KLM 1 HETSYN VERSN REVDAT 2 24-FEB-09 1KLM 1 VERSN REVDAT 1 18-MAR-98 1KLM 0 JRNL AUTH R.M.ESNOUF,J.REN,A.L.HOPKINS,C.K.ROSS,E.Y.JONES, JRNL AUTH 2 D.K.STAMMERS,D.I.STUART JRNL TITL UNIQUE FEATURES IN THE STRUCTURE OF THE COMPLEX BETWEEN JRNL TITL 2 HIV-1 REVERSE TRANSCRIPTASE AND THE JRNL TITL 3 BIS(HETEROARYL)PIPERAZINE (BHAP) U-90152 EXPLAIN RESISTANCE JRNL TITL 4 MUTATIONS FOR THIS NONNUCLEOSIDE INHIBITOR. JRNL REF PROC.NATL.ACAD.SCI.USA V. 94 3984 1997 JRNL REFN ISSN 0027-8424 JRNL PMID 9108091 JRNL DOI 10.1073/PNAS.94.8.3984 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.L.HOPKINS,J.REN,R.M.ESNOUF,B.E.WILLCOX,E.Y.JONES,C.ROSS, REMARK 1 AUTH 2 T.MIYASAKA,R.T.WALKER,H.TANAKA,D.K.STAMMERS,D.I.STUART REMARK 1 TITL COMPLEXES OF HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITORS OF REMARK 1 TITL 2 THE HEPT SERIES REVEAL CONFORMATIONAL CHANGES RELEVANT TO REMARK 1 TITL 3 THE DESIGN OF POTENT NON-NUCLEOSIDE INHIBITORS REMARK 1 REF J.MED.CHEM. V. 39 1589 1996 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.ESNOUF,J.REN,C.ROSS,Y.JONES,D.STAMMERS,D.STUART REMARK 1 TITL MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY REMARK 1 TITL 2 NON-NUCLEOSIDE INHIBITORS REMARK 1 REF NAT.STRUCT.BIOL. V. 2 303 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.REN,R.ESNOUF,E.GARMAN,D.SOMERS,C.ROSS,I.KIRBY,J.KEELING, REMARK 1 AUTH 2 G.DARBY,Y.JONES,D.STUART,D.STAMMERS REMARK 1 TITL HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR REMARK 1 TITL 2 RT-INHIBITOR COMPLEXES REMARK 1 REF NAT.STRUCT.BIOL. V. 2 293 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.REN,R.ESNOUF,A.HOPKINS,C.ROSS,Y.JONES,D.STAMMERS,D.STUART REMARK 1 TITL THE STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH REMARK 1 TITL 2 9-CHLORO-TIBO: LESSONS FOR INHIBITOR DESIGN REMARK 1 REF STRUCTURE V. 3 915 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 5 REMARK 1 AUTH D.K.STAMMERS,D.O.SOMERS,C.K.ROSS,I.KIRBY,P.H.RAY,J.E.WILSON, REMARK 1 AUTH 2 M.NORMAN,J.S.REN,R.M.ESNOUF,E.F.GARMAN,E.Y.JONES,D.I.STUART REMARK 1 TITL CRYSTALS OF HIV-1 REVERSE TRANSCRIPTASE DIFFRACTING TO 2.2 A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 242 586 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.8 REMARK 3 NUMBER OF REFLECTIONS : 27792 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.313 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1390 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2626 REMARK 3 BIN R VALUE (WORKING SET) : 0.3395 REMARK 3 BIN FREE R VALUE : 0.3568 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 149 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7761 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.000 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 6.000 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 8.000 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : BHAP-U90152.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : BHAP-U90152.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DUE TO THE LOW RATIO BETWEEN THE NUMBER REMARK 3 OF REFLECTIONS AND THE NUMBER OF PARAMETERS TO BE REFINED, ATOMS REMARK 3 DISTANT FROM THE NNI-BINDING SITE (DEFINED AS ATOMS MORE THAN 25 REMARK 3 ANGSTROM FROM THE CA ATOM OF TYR 188) WERE TIGHTLY RESTRAINED TO REMARK 3 THEIR POSITION IN THE NINE-DOMAIN RIGID-BODY REFINED MODEL OF RT- REMARK 3 MKC-442 COMPLEX, AND STRONG STEREOCHEMICAL RESTRAINTS WERE REMARK 3 EMPLOYED IN THE REFINEMENT. CROSS-VALIDATION WAS ONLY USED IN REMARK 3 THE FIRST ROUND OF REFINEMENT FROM WHICH THE ABOVE FREE R VALUES REMARK 3 AND R VALUES ARE TAKEN. THE ABOVE THERMAL FACTOR AND RMS REMARK 3 DEVIATIONS OF THE STEREOCHEMISTRY ARE TAKEN FROM THE FINAL MODEL REMARK 3 WHICH WAS REFINED USING THE WHOLE DATA SET. THE FINAL R FACTOR REMARK 3 FOR THE WHOLE DATA SET IS 0.222. REMARK 4 REMARK 4 1KLM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174454. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-95 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.995 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27792 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.8 REMARK 200 DATA REDUNDANCY : 3.010 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.54 REMARK 200 R MERGE FOR SHELL (I) : 0.43900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: RT-MKC-442 COMPLEX REMARK 200 REMARK 200 REMARK: ALL DATA INCLUDED APART FROM OUTLIERS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 68.40000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 68.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 1 REMARK 465 LYS A 540 REMARK 465 GLY A 541 REMARK 465 ILE A 542 REMARK 465 GLY A 543 REMARK 465 GLY A 544 REMARK 465 ASN A 545 REMARK 465 GLU A 546 REMARK 465 GLN A 547 REMARK 465 VAL A 548 REMARK 465 ASP A 549 REMARK 465 LYS A 550 REMARK 465 LEU A 551 REMARK 465 VAL A 552 REMARK 465 SER A 553 REMARK 465 ALA A 554 REMARK 465 GLY A 555 REMARK 465 ILE A 556 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 VAL A 559 REMARK 465 LEU A 560 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 ILE B 5 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 GLN B 91 REMARK 465 LEU B 92 REMARK 465 GLY B 93 REMARK 465 ILE B 94 REMARK 465 PRO B 95 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 ILE B 434 REMARK 465 VAL B 435 REMARK 465 GLY B 436 REMARK 465 ALA B 437 REMARK 465 GLU B 438 REMARK 465 THR B 439 REMARK 465 PHE B 440 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 49.21 -96.49 REMARK 500 PRO A 14 98.31 -56.51 REMARK 500 ILE A 50 -164.28 -124.46 REMARK 500 ASN A 54 107.66 178.28 REMARK 500 LYS A 66 125.55 -23.91 REMARK 500 ASP A 67 46.32 35.28 REMARK 500 LYS A 70 111.10 -169.85 REMARK 500 GLN A 91 97.28 -50.00 REMARK 500 ILE A 135 96.65 -66.97 REMARK 500 ASN A 136 77.21 61.61 REMARK 500 ASN A 137 55.60 32.29 REMARK 500 GLU A 138 -80.16 -139.56 REMARK 500 MET A 184 -130.89 55.21 REMARK 500 ASP A 185 34.01 -95.84 REMARK 500 GLU A 224 -63.16 -101.18 REMARK 500 PRO A 225 -168.23 -61.66 REMARK 500 PHE A 227 105.11 -59.91 REMARK 500 MET A 230 85.48 41.65 REMARK 500 LYS A 238 -169.94 -175.15 REMARK 500 PRO A 243 121.04 -35.76 REMARK 500 ASP A 250 34.83 -99.30 REMARK 500 SER A 251 109.05 -161.27 REMARK 500 ILE A 270 -61.86 -99.44 REMARK 500 ALA A 288 146.59 -177.62 REMARK 500 LYS A 311 42.77 -94.56 REMARK 500 PRO A 345 132.64 -32.87 REMARK 500 PHE A 346 -13.03 68.34 REMARK 500 MET A 357 96.29 -63.20 REMARK 500 ARG A 358 90.10 -60.12 REMARK 500 HIS A 361 106.96 -167.41 REMARK 500 THR A 403 -9.99 -57.31 REMARK 500 PRO A 412 -169.71 -57.48 REMARK 500 GLN A 500 5.57 -69.78 REMARK 500 LYS B 65 -146.46 -129.85 REMARK 500 ASP B 67 -6.26 97.93 REMARK 500 LYS B 70 94.79 -58.94 REMARK 500 ASN B 136 9.90 58.43 REMARK 500 MET B 184 -122.05 53.66 REMARK 500 ILE B 195 -60.78 -25.06 REMARK 500 ARG B 211 26.87 -74.09 REMARK 500 TRP B 212 -65.34 -137.17 REMARK 500 TRP B 239 82.36 -67.42 REMARK 500 ILE B 270 -60.89 -101.39 REMARK 500 GLN B 343 -37.58 -134.42 REMARK 500 PHE B 346 -19.15 78.31 REMARK 500 HIS B 361 -37.18 -35.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SPP A 999 DBREF 1KLM A 1 560 UNP P04585 POL_HV1H2 587 1146 DBREF 1KLM B 1 440 UNP P04585 POL_HV1H2 587 1026 SEQADV 1KLM CSD A 280 UNP P04585 CYS 435 MODIFIED RESIDUE SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU CSD LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN ARG GLY ARG GLN LYS VAL VAL THR SEQRES 37 A 560 LEU THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS VAL SEQRES 44 A 560 LEU SEQRES 1 B 440 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 440 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 440 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 440 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 440 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 440 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 440 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 440 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 440 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 440 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 440 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 440 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 440 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 440 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 440 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 440 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 440 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 440 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 440 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 440 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 440 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 440 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 B 440 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 440 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 440 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 440 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 440 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 440 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 440 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 440 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 440 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 440 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 440 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 440 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE MODRES 1KLM CSD A 280 CYS 3-SULFINOALANINE HET CSD A 280 8 HET SPP A 999 32 HETNAM CSD 3-SULFINOALANINE HETNAM SPP (1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4- HETNAM 2 SPP [METHYLAMINO)PYRIDINYL]PIPERAZINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE HETSYN SPP DELAVIRDINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 3 SPP C22 H28 N6 O3 S FORMUL 4 HOH *72(H2 O) HELIX 1 1 GLU A 28 GLU A 44 1 17 HELIX 2 2 ARG A 78 ARG A 83 1 6 HELIX 3 3 PRO A 97 GLY A 99 5 3 HELIX 4 4 GLY A 112 SER A 117 5 6 HELIX 5 5 PHE A 124 THR A 128 5 5 HELIX 6 6 SER A 156 GLN A 174 1 19 HELIX 7 7 ILE A 195 TRP A 212 1 18 HELIX 8 8 VAL A 254 GLN A 269 1 16 HELIX 9 9 ARG A 277 LEU A 279 5 3 HELIX 10 10 GLU A 297 LYS A 311 1 15 HELIX 11 11 ASP A 364 TRP A 383 1 20 HELIX 12 12 LYS A 395 GLU A 404 1 10 HELIX 13 13 ASN A 474 GLN A 487 1 14 HELIX 14 14 LEU A 503 ALA A 508 1 6 HELIX 15 15 GLU A 516 LYS A 527 1 12 HELIX 16 16 GLU B 28 LYS B 43 1 16 HELIX 17 17 ARG B 78 ARG B 83 1 6 HELIX 18 18 LEU B 100 LYS B 102 5 3 HELIX 19 19 VAL B 111 SER B 117 5 7 HELIX 20 20 GLU B 122 THR B 128 1 7 HELIX 21 21 ILE B 135 ASN B 137 5 3 HELIX 22 22 LYS B 154 GLN B 174 1 21 HELIX 23 23 ILE B 195 LEU B 210 1 16 HELIX 24 24 PRO B 236 LYS B 238 5 3 HELIX 25 25 VAL B 254 GLN B 269 1 16 HELIX 26 26 ARG B 277 LEU B 283 1 7 HELIX 27 27 GLU B 297 LYS B 311 1 15 HELIX 28 28 ALA B 360 THR B 362 5 3 HELIX 29 29 ASP B 364 TRP B 383 1 20 HELIX 30 30 LYS B 395 TRP B 401 1 7 HELIX 31 31 THR B 403 TYR B 405 5 3 HELIX 32 32 PRO B 421 LEU B 429 1 9 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 N GLN A 145 O SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 LYS A 64 0 SHEET 2 B 2 TRP A 71 VAL A 75 -1 N LEU A 74 O PHE A 61 SHEET 1 C 2 SER A 105 ASP A 110 0 SHEET 2 C 2 ASP A 186 SER A 191 -1 N SER A 191 O SER A 105 SHEET 1 D 2 TYR A 232 LEU A 234 0 SHEET 2 D 2 TRP A 239 VAL A 241 -1 N THR A 240 O GLU A 233 SHEET 1 E 5 TRP A 414 PHE A 416 0 SHEET 2 E 5 LYS A 388 LEU A 391 1 N PHE A 389 O GLU A 415 SHEET 3 E 5 ILE A 326 LYS A 331 1 N ALA A 327 O LYS A 388 SHEET 4 E 5 TRP A 337 TYR A 342 -1 N TYR A 342 O ILE A 326 SHEET 5 E 5 ASN A 348 TYR A 354 -1 N TYR A 354 O TRP A 337 SHEET 1 F 5 GLN A 464 THR A 470 0 SHEET 2 F 5 LEU A 452 THR A 459 -1 N TYR A 457 O LYS A 465 SHEET 3 F 5 GLU A 438 ASN A 447 -1 N ASN A 447 O LEU A 452 SHEET 4 F 5 GLU A 492 THR A 497 1 N ASN A 494 O GLU A 438 SHEET 5 F 5 LYS A 530 TRP A 535 1 N LYS A 530 O VAL A 493 SHEET 1 G 3 ILE B 47 LYS B 49 0 SHEET 2 G 3 ILE B 142 TYR B 146 -1 N GLN B 145 O SER B 48 SHEET 3 G 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 H 2 VAL B 60 ILE B 63 0 SHEET 2 H 2 ARG B 72 VAL B 75 -1 N LEU B 74 O PHE B 61 SHEET 1 I 3 SER B 105 ASP B 110 0 SHEET 2 I 3 ASP B 186 SER B 191 -1 N SER B 191 O SER B 105 SHEET 3 I 3 VAL B 179 TYR B 183 -1 N TYR B 183 O ASP B 186 SHEET 1 J 5 TRP B 414 PHE B 416 0 SHEET 2 J 5 LYS B 388 LEU B 391 1 N PHE B 389 O GLU B 415 SHEET 3 J 5 ILE B 326 GLY B 333 1 N ALA B 327 O LYS B 388 SHEET 4 J 5 GLN B 336 TYR B 342 -1 N TYR B 342 O ILE B 326 SHEET 5 J 5 ASN B 348 ALA B 355 -1 N TYR B 354 O TRP B 337 LINK C LEU A 279 N CSD A 280 1555 1555 1.33 LINK C CSD A 280 N LYS A 281 1555 1555 1.33 CISPEP 1 PRO A 420 PRO A 421 0 -0.08 SITE 1 AC1 15 LEU A 100 LYS A 101 LYS A 102 LYS A 103 SITE 2 AC1 15 VAL A 106 TYR A 181 TYR A 188 GLU A 224 SITE 3 AC1 15 PRO A 225 PRO A 226 PHE A 227 LEU A 234 SITE 4 AC1 15 HIS A 235 PRO A 236 TYR A 318 CRYST1 136.800 109.400 72.000 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007310 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009141 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013889 0.00000